Position in AGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,167,221
+$2,003,582 QoQ
Shares Held
1,035,040
+197.1% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. AGEN ranks #279 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in AGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,167,221 | 1,035,040 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,163,639 | 348,395 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,170,428 | 372,748 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,335,915 | 346,991 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,450,558 | 317,409 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $821,649 | 544,139 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,303,104 | 475,586 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,647,162 | 483,059 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,554,970 | 451,043 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,697,777 | 8,099,616 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,563,275 | 7,907,561 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,039,728 | 7,114,804 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,384,332 | 6,490,208 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,399,215 | 5,525,794 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,598,455 | 5,249,357 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,875,354 | 4,817,249 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,604,213 | 4,435,167 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,480,383 | 3,853,817 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,201,198 | 4,099,752 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $18,975,395 | 3,614,361 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,591,083 | 3,386,354 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,625,115 | 2,803,350 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,815,148 | 2,457,595 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,979,106 | 2,244,778 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,042,413 | 2,046,417 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,828,419 | 1,562,619 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||